Post transplant lymphoproliferative disorders following reduced intensity conditioning with in vivo T cell depletion.
Peggs
K S
KS
Banerjee
L
L
Thomson
K
K
Mackinnon
S
S
D000328:Adult; D000961:Antilymphocyte Serum / Q000009:adverse effects; D001402:B-Lymphocytes / Q000276:immunology; D016026:Bone Marrow Transplantation / Q000009:adverse effects*; D003586:Cytomegalovirus Infections / Q000453:epidemiology / Q000209:etiology; D005260:Female; D006086:Graft vs Host Disease / Q000517:prevention & control; D006801:Humans; D008212:Lymphocyte Depletion / Q000009:adverse effects / Q000379:methods*; D017710:Lymphocyte Transfusion / Q000009:adverse effects; D008232:Lymphoproliferative Disorders / Q000209:etiology* / Q000276:immunology; D009190:Myelodysplastic Syndromes / Q000628:therapy*; D013601:T-Lymphocytes / Q000276:immunology
D000961:Antilymphocyte Serum